Latest National Institute of Allergy and Infectious Diseases Stories
Unprecedented international consortium -- including the University of Maryland School of Medicine and NIH -- now assembled to accelerate collaborative multi-site trials of candidate Ebola vaccine
PRINCETON, N.J., Aug. 11, 2014 /PRNewswire/ -- Soligenix, Inc.
Awarded $2.1 million in additional funding PRINCETON, N.J., Aug. 1, 2014 /PRNewswire/ -- Soligenix, Inc.
MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID),
The Mississippi infant believed to have been cured of HIV following an extended remission now once again has “detectable levels” of the AIDS-causing virus in her blood.
Prestigious Biomedical Researcher and Author Joins Innovator in DNA Capture Technology SAN DIEGO, July 7, 2014 /PRNewswire/ -- Diomics, an innovator in DNA capture technology, today
SAN DIEGO, July 1, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Center will utilize next generation genomic sequencing and analysis technologies to better understand infectious disease pathogens, and create resource for the research community ROCKVILLE,
Clinicians treating patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus (MERS-CoV), a virus first detected in humans in 2012 that has since caused 614 laboratory-confirmed infections, including 181 that were fatal.
PRINCETON, N.J., May 12, 2014 /PRNewswire/ -- Soligenix, Inc.
- A political dynamiter.